Skye Bioscience, Inc. (SKYE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Skye Bioscience, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.53x | -3.89x | -0.51x | -0.46x | -2.48x | -1.41x |
| P/B Ratio | 1.48x | 1.52x | -8.94x | -2.95x | 3.61x | 20.48x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 3.30x | 16.32x | 0.84x | 0.74x | 2.46x | 3.38x |
| Quick Ratio | 3.30x | 16.32x | 0.84x | 0.74x | 2.46x | 3.38x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.01x | -2.16x | -0.66x | 0.36x | 3.32x |
YoY = year-over-year change. Source: FMP..